Molecular Hybridization as a Strategy for Developing Artemisinin-Derived Anticancer Candidates by Elena Marchesi, Daniela Perrone, Maria Luisa Navacchia

Connect to this object online.

In Vitro Studies to Evaluate the Intestinal Permeation of an Ursodeoxycholic Acid-Conjugated Oligonucleotide for Duchenne Muscular Dystrophy Treatment by Marika Faiella, Giada Botti, Alessandro Dalpiaz, Lorenzo Gnudi, Aurélie Goyenvalle, Barbara Pavan, Daniela Perrone, Matteo Bovolenta, Elena Marchesi

Connect to this object online.

Multiple Sclerosis Treatment in the COVID-19 Era: A Risk-Benefit Approach by Paolo Immovilli, Nicola Morelli, Chiara Terracciano, Eugenia Rota, Elena Marchesi, Stefano Vollaro, Paola De Mitri, Domenica Zaino, Veronica Bazzurri, Donata Guidetti

Connect to this object online.

The Impact of Highly Effective Treatment in Pediatric-Onset Multiple Sclerosis: A Case Series by Paolo Immovilli, Paola De Mitri, Veronica Bazzurri, Stefano Vollaro, Nicola Morelli, Giacomo Biasucci, Fabiola Magnifico, Elena Marchesi, Maria Lara Lombardelli, Lorenza Gelati, Donata Guidetti

Connect to this object online.

Evaluation of the Anticancer Activity of a Bile Acid-Dihydroartemisinin Hybrid Ursodeoxycholic-Dihydroartemisinin in Hepatocellular Carcinoma Cells by Tzu-En Huang, Yi-Ning Deng, Jui-Ling Hsu, Wohn-Jenn Leu, Elena Marchesi, Massimo L. Capobianco, Paolo Marchetti, Maria Luisa Navacchia, Jih-Hwa Guh, Daniela Perrone, Lih-Ching Hsu

Connect to this object online.